• A+
  • A
  • A-

Contact information

St-Elisabeth site - Uccle
02-614 20 00
St-Michel site - Etterbeek
02-614 30 00
Bella Vita Medical Center - Waterloo
02-614 42 00

Antibiotic Therapy Management Group (GGA)

The Antibiotic Therapy Management Group (GGA) is a multidisciplinary committee whose objective is to promote the rational use of anti-infectious agents in order to improve treatment results and combat growing resistance, in collaboration with medical teams, pharmaceutical services, management, patients and external partners.


The Antibiotic Therapy Management Group ("GGA") of the Europe Hospitals is pleased to announce its participation in the EUDIPA study. This study is part of the global fight against antimicrobial resistance. The study protocol has been developed by the National Surveillance of Infections in Healthcare Settings (NSIH) and the National Antibiogram Committee (NAC). You can find the link to the study here.

The Europe Hospitals are taking part in this voluntary, retrospective, observational, multicentre study. The study includes the analysis of antimicrobial therapies prescribed after a susceptibility test on samples containing the Pseudomonas aeruginosa germ in adult patients.
A retrospective study reviews information from the past. The period concerned is from 11 November 2021 to 10 November 2022. All data extracted will be anonymised (a return to your personal file is no longer possible).

This study was approved by the Cliniques de l'Europe ethics committee on 20 November 2023.
You can refuse to allow your medical data to be used for this study by sending an e-mail to info@cdle.be. This refusal will have no effect on the quality of care you receive in our establishment.

We wish you a pleasant stay, 

The Europe Hospitals Antibiotic Therapy Management Group


Groupe de Gestion de l’Antibiothérapie (GGA)
Dernière modification